Plk1: unexpected roles in DNA replication

被引:33
作者
Mandal, Ranadip [1 ]
Strebhardt, Klaus [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Gynecol & Obstet, D-60590 Frankfurt, Germany
关键词
POLO-LIKE KINASE-1; CANCER-THERAPY; CENTROSOME; PHOSPHORYLATION; PROGRESSION; ACTIVATION; CELLS;
D O I
10.1038/cr.2013.130
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FOR20, a conserved centrosomal protein, is essential for Plk1 to localize to the centrosome during the S phase and regulate DNA replication. The absence of either Plk1 or FOR20 can stall the cell cycle by a previously unknown intra-S phase centrosomal checkpoint.
引用
收藏
页码:1251 / 1253
页数:3
相关论文
共 50 条
  • [21] Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis
    Zhu, Yuanyuan
    Wang, Chong
    Lan, Jianping
    Yu, Jian
    Jin, Changjiang
    Huang, He
    [J]. EXPERIMENTAL CELL RESEARCH, 2012, 318 (18) : 2344 - 2352
  • [22] PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1
    Li, Xuetao
    Chen, Guangliang
    Liu, Bin
    Tao, Zhennan
    Wu, Yue
    Zhang, Kai
    Feng, Zibin
    Huang, Yulun
    Wang, Hao
    [J]. CELL DEATH DISCOVERY, 2023, 9 (01)
  • [23] Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer
    Li, Jie
    Wang, Ruixin
    Schweickert, Patrick G.
    Karki, Anju
    Yang, Yi
    Kong, Yifan
    Ahmad, Nihal
    Konieczny, Stephen F.
    Liu, Xiaoqi
    [J]. CELL CYCLE, 2016, 15 (05) : 711 - 719
  • [24] PLK1 is required for chromosome compaction and microtubule organization in mouse oocytes
    Little, Tara M.
    Jordan, Philip W.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2020, 31 (12) : 1206 - 1217
  • [25] Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
    Song, Bing
    Liu, X. Shawn
    Rice, Steven J.
    Kuang, Shihuan
    Elzey, Bennett D.
    Konieczny, Stephen F.
    Ratliff, Timothy L.
    Hazbun, Tony
    Chiorean, Elena G.
    Liu, Xiaoqi
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (01) : 58 - 68
  • [26] PLK1 regulates CtIP and DNA2 interplay in long-range DNA end resection
    Ceppi, Ilaria
    Cannavo, Elda
    Bret, Helene
    Camarillo, Rosa
    Vivalda, Francesca
    Thakur, Roshan Singh
    Romero-Franco, Amador
    Sartori, Alessandro A.
    Huertas, Pablo
    Guerois, Raphael
    Cejka, Petr
    [J]. GENES & DEVELOPMENT, 2023, 37 (3-4) : 119 - 135
  • [27] PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy
    Ruf, Stefanie
    Heberle, Alexander Martin
    Langelaar-Makkinje, Miriam
    Gelino, Sara
    Wilkinson, Deepti
    Gerbeth, Carolin
    Schwarz, Jennifer Jasmin
    Holzwarth, Birgit
    Warscheid, Bettina
    Meisinger, Chris
    van Vugt, Marcel A. T. M.
    Baumeister, Ralf
    Hansen, Malene
    Thedieck, Kathrin
    [J]. AUTOPHAGY, 2017, 13 (03) : 486 - 505
  • [28] Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
    Fan, Weiqiang
    Ma, Huan
    Jin, Bin
    [J]. ONCOLOGY LETTERS, 2022, 23 (05)
  • [29] PLK1 inhibition in cancer therapy: potentials and challenges
    Elsayed, Inas
    Wang, Xiaosheng
    [J]. FUTURE MEDICINAL CHEMISTRY, 2019, 11 (12) : 1383 - 1386
  • [30] Plk1 phosphorylation of Topors is involved in its degradation
    Xiaoming Yang
    Hongchang Li
    Anping Deng
    Xiaoqi Liu
    [J]. Molecular Biology Reports, 2010, 37 : 3023 - 3028